
|Articles|September 1, 1999
The American Journal of Managed Care
- September 1999
- Volume 5
- Issue 9
Selective Contracting and Patient Outcomes: A Case Study of Formulary Restrictions for Selective Serotonin Reuptake Inhibitor Antidepressants
Advertisement
Articles in this issue
about 26 years ago
Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?about 26 years ago
Drug Therapy of Allergic Rhinitisabout 26 years ago
Rethinking Formulary Strategy: Management and Measurement ConsiderationsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
2
Patients Face New Care Complexities as DTC Options Expand
3
Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers
4
Louisiana Delivers Innovative Cancer Treatments, but Ensuring Access Is a Work in Progress
5














































